Japan
· Delayed Price · Currency is JPY Mizuho Medy Company Description
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan.
The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits.
It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits.
In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. Mizuho Medy Co.,Ltd. was incorporated in 1977 and is headquartered in Tosu, Japan.
| Country | Japan |
| Founded | 1977 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 187 |
| CEO | Fuminari Karakawa |
Contact Details
Address: 5-4 Fujinoki-machi Tosu, 841-0048 Japan | |
| Phone | 81 9 4285 0303 |
| Website | mizuho-m.co.jp |
Stock Details
| Ticker Symbol | 4595 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3885900005 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Fuminari Karakawa | Chief Executive Officer |